Tucuvi, a Spanish healthcare AI startup, has raised a €17 million Series A (about $20 million) to speed adoption of its AI-based care management platform in healthcare systems.
The round was led by Cathay Innovation and Kfund (through its early-growth fund, Leadwind), with participation from existing investors Frontline Ventures, Seaya Ventures and Shilling.
Tucuvi says it built the company to respond to mounting strain on health systems, citing a shortage of professionals, rising demand and increasing operational complexity.
Its platform is designed to automate and orchestrate high-volume clinical and care coordination workflows end to end. One piece of that is “LOLA,” a voice agent that calls patients, runs clinical and coordination flows, and escalates to human teams when needed.
The company says the platform now supports more than 50 workflows, spanning post-surgical and discharge follow-ups, chronic disease management, pre-op assessments, test preparation, screening programs, scheduling and demand management.
CEO María González framed the pitch as moving beyond point tools: “Healthcare is under enormous pressure, and partial solutions are no longer enough.” She added: “We’re proud to already be working with more than 60 healthcare organizations, and we’re continuing to grow to meet increasingly strong demand.”
On the regulatory side, Tucuvi announced in October 2025 that it is the first AI platform to receive European regulatory approval as Class IIb Software as a Medical Device (SaMD) for both its voice agent and its patient management platform. It also claims results including up to 80% automation of nursing follow-up workflows, patient reach and adherence above 90%, and a 5.5% reduction in readmissions for EPOC.
